http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014520862-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-40 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014520862-A |
| titleOfInvention | Thiophene-2-carboxylic acid derivatives useful as inhibitors of Flaviviridae virus |
| abstract | Provided are compounds of formula I and pharmaceutically acceptable salts and esters thereof. The provided compounds, compositions and methods are useful for the treatment of Flaviviridae virus infection (eg, hepatitis C infection), particularly drug resistant Flaviviridae virus infection. In another aspect, there is provided the use of a compound of formula I for the manufacture of a medicament for the treatment of Flaviviridae virus infection. In one embodiment, the viral infection is an acute or chronic HCV infection. |
| priorityDate | 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 492.